Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation

The high morbidity of HBV reactivation following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is partially due to the intense immunologic potency of complex therapeutic regimens, the use of antithymocyte globulin and calcineurin inhibitors to prevent graft versus-host disease (GVHD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yibo, Huang, He, Luo, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890023/
https://www.ncbi.nlm.nih.gov/pubmed/33613534
http://dx.doi.org/10.3389/fimmu.2020.610500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890023/
https://www.ncbi.nlm.nih.gov/pubmed/33613534
http://dx.doi.org/10.3389/fimmu.2020.610500

Ejemplares similares